[1]
2009. Antiangiogenic activity of zoledronic acid: inhibition of the VEGF-VEGFR-2 autocrine loop in the endothelial cells of patients with multiple myeloma. Hematology Meeting Reports (formerly Haematologica Reports). 2, 3 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i3.376.